Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian I Cardle

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|April 15, 2021
Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targetingIan I Cardle, Michael C Jensen, Suzie H Pun, et al.
Accounts of Chemical Research|August 14, 2020
Biomaterials in Chimeric Antigen Receptor T-Cell Process DevelopmentIan I Cardle, Emmeline L Cheng, Michael C Jensen, et al.
ACS Nano|January 27, 2025
<i>In Situ</i> Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer ImmunotherapiesIan I Cardle, Dylan R Scherer, Michael C Jensen, et al.
ACS Biomaterials Science & Engineering|July 19, 2023
Aptamer-Based Chromatographic Methods for Efficient and Economical Separation of Leukocyte PopulationsMelissa Ling, Ian I Cardle, Kefan Song, et al.
Analytical Biochemistry|February 22, 2019
anti-EGFR capture mitigates EMT- and chemoresistance-associated heterogeneity in a resistance-profiling CTC platformFredrik I Thege, Conor N Gruber, Ian I Cardle, et al.
Plos One|May 26, 2022
Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroidsFredrik I Thege, Ian I Cardle, Conor N Gruber, et al.
Nature Biomedical Engineering|June 19, 2019
Traceless aptamer-mediated isolation of CD8<sup>+</sup> T cells for chimeric antigen receptor T-cell therapyNataly Kacherovsky, Ian I Cardle, Emmeline L Cheng, et al.
Advanced Healthcare Materials|December 15, 2018
Cell-Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen-Presenting Cells for T Cell ActivationBrynn R Olden, Caleb R Perez, Ashley L Wilson, et al.
Journal of the American Chemical Society|May 21, 2026
Discovery and Cryo-EM-Guided Development of a Neuropilin-2-Binding Aptamer for Receptor AntagonismKairui Jiang, Nataly Kacherovsky, Tong Wang, et al.
Journal of the American Chemical Society|July 25, 2022
Discovery of a Transferrin Receptor 1-Binding Aptamer and Its Application in Cancer Cell Depletion for Adoptive T-Cell Therapy ManufacturingEmmeline L Cheng, Ian I Cardle, Nataly Kacherovsky, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|April 15, 2021
Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targetingIan I Cardle, Michael C Jensen, Suzie H Pun, et al.
Accounts of Chemical Research|August 14, 2020
Biomaterials in Chimeric Antigen Receptor T-Cell Process DevelopmentIan I Cardle, Emmeline L Cheng, Michael C Jensen, et al.
ACS Nano|January 27, 2025
<i>In Situ</i> Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer ImmunotherapiesIan I Cardle, Dylan R Scherer, Michael C Jensen, et al.
ACS Biomaterials Science & Engineering|July 19, 2023
Aptamer-Based Chromatographic Methods for Efficient and Economical Separation of Leukocyte PopulationsMelissa Ling, Ian I Cardle, Kefan Song, et al.
Analytical Biochemistry|February 22, 2019
anti-EGFR capture mitigates EMT- and chemoresistance-associated heterogeneity in a resistance-profiling CTC platformFredrik I Thege, Conor N Gruber, Ian I Cardle, et al.
Plos One|May 26, 2022
Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroidsFredrik I Thege, Ian I Cardle, Conor N Gruber, et al.
Nature Biomedical Engineering|June 19, 2019
Traceless aptamer-mediated isolation of CD8<sup>+</sup> T cells for chimeric antigen receptor T-cell therapyNataly Kacherovsky, Ian I Cardle, Emmeline L Cheng, et al.
Advanced Healthcare Materials|December 15, 2018
Cell-Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen-Presenting Cells for T Cell ActivationBrynn R Olden, Caleb R Perez, Ashley L Wilson, et al.
Journal of the American Chemical Society|May 21, 2026
Discovery and Cryo-EM-Guided Development of a Neuropilin-2-Binding Aptamer for Receptor AntagonismKairui Jiang, Nataly Kacherovsky, Tong Wang, et al.
Journal of the American Chemical Society|July 25, 2022
Discovery of a Transferrin Receptor 1-Binding Aptamer and Its Application in Cancer Cell Depletion for Adoptive T-Cell Therapy ManufacturingEmmeline L Cheng, Ian I Cardle, Nataly Kacherovsky, et al.
Pageof 2